Report for: Stavudine Toxicity in Adult Longer-Term ART Patients in Blantyre, Malawi

Title	Stavudine Toxicity in Adult Longer-Term ART Patients in Blantyre, Malawi
Published in	PLOS ONE, July 2012
DOI	10.1371/journal.pone.0042029
Pubmed ID	22848696
Authors	Joep J. van Oosterhout, Jane Mallewa, Symon Kaunda, Newton Chagoma, Yassin Njalale, Elizabeth Kampira, Mavuto Mukaka, Robert S. Heyderman
Abstract	Stavudine is an effective and inexpensive antiretroviral drug, but no longer recommended by WHO for first-line antiretroviral regimens in resource-limited settings due to toxicity concerns. Because of the high cost of alternative drugs, it has not been feasible to replace stavudine in most adults in the Malawi ART programme. We aimed to provide policy makers with a detailed picture of stavudine toxicities in Malawians on longer-term ART, in order to facilitate prioritization of stavudine replacement among other measures to improve the quality of ART programmes.

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
United States	2	100%

Type	Count	As %
Members of the public	2	100%

Mendeley readers

The data shown below were compiled from readership statistics for 91 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Readers by professional status	Count	As %
Researcher	16	18%
Student > Master	13	14%
Student > Ph. D. Student	7	8%
Student > Bachelor	5	5%
Student > Doctoral Student	5	5%
Other	23	25%
Unknown	22	24%

Readers by discipline	Count	As %
Medicine and Dentistry	24	26%
Social Sciences	12	13%
Nursing and Health Professions	7	8%
Pharmacology, Toxicology and Pharmaceutical Science	5	5%
Agricultural and Biological Sciences	4	4%
Other	13	14%
Unknown	26	29%

PLOS